ViewRay : First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy Trial
UF startup ViewRay, Inc. announces the enrollment of the first patient in the Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial, a multi-center... Read More
IMHC Scientists Create Exoskeleton That Lets Paralyzed Walk
Pensacola scientists who created a robotic exoskeleton allowing paralyzed people to move are among five finalists in an international competition sponsored by Toyota. The... Read More
Cannabis Users Drive High, and Crashes Are on the Rise
As cannabis legalization spreads across North America, there is a growing realization of the public safety issues surrounding widespread use of the... Read More
Province Expands TAO Connect Mental Health Service
An online therapy service first used on a trial-basis in Newfoundland and Labrador is now expanding province-wide. UF startup and UF Innovate... Read More
Entrinsic Health Solutions and Markey Cancer Center Launch Phase II Study for Neuroendocrine Tumor Patients with Quality of Life-Limiting Diarrhea
UF startup Entrinsic Health Solutions in partnership with the University of Kentucky (UK) Markey Cancer Center announced initiation of active accrual and first consented... Read More
AxoGen Announces Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions... Read More
‘Most Innovative’ Products Are a Magnificent Seven
Connect, San Diego’s oldest startup accelerator, recognized seven companies with ground-breaking technologies on Nov. 29. Pared down from a pool of 23... Read More
Positive Payor Policy Covering coflex® by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis
On Nov. 1, UF startup RTI Surgical announced it would acquire Paradigm Spine. Its coflex® has gotten Positive Commercial Payor Policies from... Read More
Nash Pharmaceuticals Announces Positive Pre-Clinical Results For Its Lead Compound NP-178 in a New Study for Crohn’s Disease (Globe Newswire)
Nash Pharmaceuticals Inc., a wholly owned subsidiary of UF startup Breathtec Biomedical Inc., is pleased to announce that in a recent in... Read More
DNAtrix’s Oncolytic Virus Expressing OX40 Ligand Treats First Patient in Recurrent Glioblastoma Clinical Trial (PR Newswire)
UF startup DNAtrix, a leader in oncolytic virus immunotherapies for cancer, announced the treatment of the first patient with DNX-2440, an oncolytic... Read More
